Evolent Health, Inc. (FRA:9EH)

Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of EUR 384.00 million. The enterprise value is 1.21 billion.

Market Cap	384.00M
Enterprise Value	1.21B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	111.60M
Shares Outstanding	n/a
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-1.57%
Owned by Insiders (%)	1.76%
Owned by Institutions (%)	103.58%
Float	86.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	16.42
PS Ratio	0.22
PB Ratio	0.53
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.57, with an EV/FCF ratio of -12.29.

EV / Earnings	-7.88
EV / Sales	0.69
EV / EBITDA	16.57
EV / EBIT	274.67
EV / FCF	-12.29

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 1.29.

Current Ratio	1.33
Quick Ratio	1.17
Debt / Equity	1.29
Debt / EBITDA	12.78
Debt / FCF	-9.33
Interest Coverage	0.10

Financial Efficiency

Return on equity (ROE) is -12.40% and return on invested capital (ROIC) is 0.15%.

Return on Equity (ROE)	-12.40%
Return on Assets (ROA)	0.12%
Return on Invested Capital (ROIC)	0.15%
Return on Capital Employed (ROCE)	0.23%
Revenue Per Employee	389,037
Profits Per Employee	-34,260
Employee Count	4,500
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

In the past 12 months, Evolent Health has paid 366,489 in taxes.

Income Tax	366,489
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-70.16%
50-Day Moving Average	5.69
200-Day Moving Average	7.66
Relative Strength Index (RSI)	31.78
Average Volume (20 Days)	293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.34

Income Statement

In the last 12 months, Evolent Health had revenue of EUR 1.75 billion and -154.17 million in losses. Loss per share was -1.34.

Revenue	1.75B
Gross Profit	322.46M
Operating Income	3.94M
Pretax Income	-108.88M
Net Income	-154.17M
EBITDA	68.04M
EBIT	3.94M
Loss Per Share	-1.34

Balance Sheet

The company has 99.42 million in cash and 922.46 million in debt, giving a net cash position of -823.04 million.

Cash & Cash Equivalents	99.42M
Total Debt	922.46M
Net Cash	-823.04M
Net Cash Per Share	n/a
Equity (Book Value)	717.84M
Book Value Per Share	6.43
Working Capital	119.46M

Cash Flow

In the last 12 months, operating cash flow was -30.84 million and capital expenditures -68.01 million, giving a free cash flow of -98.86 million.

Operating Cash Flow	-30.84M
Capital Expenditures	-68.01M
Free Cash Flow	-98.86M
FCF Per Share	n/a

Margins

Gross margin is 18.42%, with operating and profit margins of 0.23% and -6.24%.

Gross Margin	18.42%
Operating Margin	0.23%
Pretax Margin	-6.22%
Profit Margin	-6.24%
EBITDA Margin	3.89%
EBIT Margin	0.23%
FCF Margin	n/a

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-40.15%
FCF Yield	-25.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evolent Health has an Altman Z-Score of 0.91 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.91
Piotroski F-Score	4